삼성융합의과학원
의료기기산업학과

Research interests are the field of glycomics and glycobiology, expecially on sphingolipid, ceramide and sialic acid-containing sphingolipids, ganglioside. Academic findings: Hepatic B Viral hepatocarcinoma and PTEN (Cancer Res 2003), asialo-1 acid glycoprotein in liver cirrhosis and carcinoma (Hepatol Res, 2003), GlcNAc:βMan1,4GlcNAcT-III in hepatitis (Glycoconj J, 2003), MMP-9/2 and α-fetoproteins in HBV hepatitis (J. Gastroent Hepatol 2004), HBV metastatic (FASEB J. 2004), Hepatic GnT-V and GnT-III-ApoB100 (JBC. 2004), Disialo GD3 in VSMC (JBC. 2004), therapeutic hepatocarcinoma cells (FASEB J. 2004), TG-2 in leukemia (FEBS Lett. 2004), N-GlcNAcT-III in HBV (J Gastroent Hepatol, 2004), Monosialyl GM3 in leukemic differentiation (Glycobiology 2005), MMP-9 in IVF (British J Obstetrics and Gynecol. 2005), disialo GD3 Fas-T cells (Glycobiology 2006), GM3 in PTEN (Glycobiology 2006), ROS in sialic GD3-cell (FASEB J 2006), AP-2a in GM3-PTEN (Glycobiology 2008), sialidase in leukemia (BBA 2008), GM3-VEGFR-2 interaction (Glycobiology 2009), GD3 in breast cancer (Biological Chemistry 2009), pig CMAH and N-glycolylneuraminic acid (Biochem J 2010), pST6GalNAc IV for Neu5Aca2-3Galb1-3GalNAc (Glycoconj J 2011), GM3 in TGF-β1-induced EMT (Biochem J. 2013), VEGFR-2 in neovascularization (J Mol Medicine 2013), monosialyl GM3 (Plos One 2014) and TGF-receptor (Int. J. of Biochem. Cell Biol. 2014), Sialyl Le A/X of HBx (Mol Cancer 2014, J Cell Biochem 2015). Housekeeping promoter 5'pcmah-2 of CMP-NeuGc gene (Glycoconj 2016), GD1b Apoptosis of MCF-7 (IJMS 2016), Human ST8Sia VI (α2,8-Sialyltransferase) Gene (IJMS 2016), GD2-ICAMI (IJMS 2017), Sialyllactose VEGFR-2 activation, GD3/a1AR/TG2, AApoB100-GM3, GM3-macrophage (JCB, 2017, 2018), Sirt1-FcεRI- mast cell AMPK (Sci Rep, 2017), ASC/LPS (PloS One 2017), 4-o-cASC (JCB, JSMB 2018), SARS-CoV-2-sialylation. Lectin-Glycan (IJMS, 2020),CMP-NeuGc (Sci Rep 2019), AC (FP), 3-SL-sIGLEC (Glycoconj J 2020), Avc(FP, 2021, IJMS 2021)